标题
S100A8 and S100A9 Promote Apoptosis of Chronic Eosinophilic Leukemia Cells
作者
关键词
-
出版物
Frontiers in Immunology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-08-13
DOI
10.3389/fimmu.2020.01258
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- S100A9 Regulates MDSCs-Mediated Immune Suppression via the RAGE and TLR4 Signaling Pathways in Colorectal Carcinoma
- (2019) Mao Huang et al. Frontiers in Immunology
- Presence of S100A8/Gr1-Positive Myeloid-Derived Suppressor Cells in Primary Tumors and Visceral Organs Invaded by Breast Carcinoma Cells
- (2018) Gamze Tanriover et al. Clinical Breast Cancer
- Discovery of 4-(( N -(2-(dimethylamino)ethyl)acrylamido)methyl)- N -(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide (CHMFL-PDGFR-159) as a highly selective type II PDGFRα kinase inhibitor for PDGFRα driving chronic eosinophilic leukemia
- (2018) Qiang Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Calprotectin and the Initiation and Progression of Head and Neck Cancer
- (2018) P.P. Argyris et al. JOURNAL OF DENTAL RESEARCH
- Crucial Role of Linear Ubiquitin Chain Assembly Complex–Mediated Inhibition of Programmed Cell Death in TLR4-Mediated B Cell Responses and B1b Cell Development
- (2018) Yoshiteru Sasaki et al. JOURNAL OF IMMUNOLOGY
- Chemotactic effect of S100A8 and S100A9 on human eosinophilic leukemia cells, EoL-1 through TLR4
- (2018) Ayoung Gu et al. Molecular & Cellular Toxicology
- TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms
- (2018) Marijana Kovačić et al. CELLULAR ONCOLOGY
- S100A8/A9 in Inflammation
- (2018) Siwen Wang et al. Frontiers in Immunology
- Immunological Approaches Towards Cancer and Inflammation: A Cross Talk
- (2018) Xinglong Qu et al. Frontiers in Immunology
- Human Toll-Like Receptor 4 (hTLR4): Structural and functional dynamics in cancer
- (2018) Vinita Mishra et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Monophosphoryl lipid a attenuates radiation injury through TLR4 activation
- (2017) Jiaming Guo et al. Oncotarget
- Alarmin S100A8 Activates Alveolar Epithelial Cells in the Context of Acute Lung Injury in a TLR4-Dependent Manner
- (2017) Deblina Chakraborty et al. Frontiers in Immunology
- Myeloid neoplasms with eosinophilia
- (2016) Andreas Reiter et al. BLOOD
- Discovery and Structure–Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists
- (2016) Matthew D. Morin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lyn mediates FIP1L1-PDGFRA signal pathway facilitating IL- 5RA intracellular signal through FIP1L1-PDGFRA/JAK2/Lyn/Akt network complex in CEL
- (2016) Bin Li et al. Oncotarget
- Long-term outcomes of imatinib in patients with FIP1L1/ PDGFRA associated chronic eosinophilic leukemia: experience of a single center in China
- (2016) Shi-Qiang Qu et al. Oncotarget
- S100A8+ stroma cells predict a good prognosis and inhibit aggressiveness in colorectal carcinoma
- (2016) Si Li et al. OncoImmunology
- S100A9 expressed in ER−PgR− breast cancers induces inflammatory cytokines and is associated with an impaired overall survival
- (2015) Caroline Bergenfelz et al. BRITISH JOURNAL OF CANCER
- F604S exchange in FIP1L1-PDGFRA enhances FIP1L1-PDGFRA protein stability via SHP-2 and SRC: a novel mode of kinase inhibitor resistance
- (2015) S P Gorantla et al. LEUKEMIA
- Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment
- (2015) A Deguchi et al. ONCOGENE
- House Dust Mite Allergen Regulates Constitutive Apoptosis of Normal and Asthmatic Neutrophils via Toll-Like Receptor 4
- (2015) Do Hyung Kim et al. PLoS One
- Identification of Ponatinib as a potent inhibitor of growth, migration, and activation of neoplastic eosinophils carrying FIP1L1-PDGFRA
- (2014) Irina Sadovnik et al. EXPERIMENTAL HEMATOLOGY
- TLR4 Ligands Lipopolysaccharide and Monophosphoryl Lipid A Differentially Regulate Effector and Memory CD8+ T Cell Differentiation
- (2014) W. Cui et al. JOURNAL OF IMMUNOLOGY
- Proteomics-Based Strategies To Identify Proteins Relevant to Chronic Lymphocytic Leukemia
- (2014) Suliman A. Alsagaby et al. JOURNAL OF PROTEOME RESEARCH
- Ponatinib efficiently kills imatinib-resistant chronic eosinophilic leukemia cells harboring gatekeeper mutant T674I FIP1L1-PDGFRα: roles of Mcl-1 and β-catenin
- (2014) Yanli Jin et al. Molecular Cancer
- S100A8 Contributes to Drug Resistance by Promoting Autophagy in Leukemia Cells
- (2014) Minghua Yang et al. PLoS One
- Oncostatin M is a FIP1L1/PDGFRA-dependent mediator of cytokine production in chronic eosinophilic leukemia
- (2013) G. Hoermann et al. ALLERGY
- Cyclin-Dependent Kinase 7/9 Inhibitor SNS-032 Abrogates FIP1-like-1 Platelet-Derived Growth Factor Receptor and Bcr-Abl Oncogene Addiction in Malignant Hematologic Cells
- (2012) Y. Wu et al. CLINICAL CANCER RESEARCH
- Inflammation-associated S100 proteins: new mechanisms that regulate function
- (2010) Jesse Goyette et al. AMINO ACIDS
- Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients
- (2010) E Nicolas et al. LEUKEMIA
- Long-term exposure of leukemia cells to multi-targeted tyrosine kinase inhibitor induces activations of AKT, ERK and STAT5 signaling via epigenetic silencing of the PTEN gene
- (2010) C Nishioka et al. LEUKEMIA
- Triptolide abrogates oncogene FIP1L1-PDGFRα addiction and induces apoptosis in hypereosinophilic syndrome
- (2009) Yanli Jin et al. CANCER SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started